Common Cold |
Cold, Common |
Clinical Trial: Evaluation of Echinacea for the Common Cold
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to determine whether three Echinacea preparations with different chemical compositions are effective for prevention or treatment of the common cold.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Common Cold | Drug: Echinacea | Phase II |
MedlinePlus related topics: Common Cold
Study Type: Interventional
Study Design: Prevention, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Evaluation of Echinacea in a Human Rhinovirus Challenge
Study start: September 2001; Study completion: May 2004
Echinacea is a widely used herbal remedy for the common cold. Previous clinical trials designed to assess the efficacy of Echinacea for prevention or treatment of the common cold have produced inconsistent results. A variety of different Echinacea products have been used in these clinical trials. Recent studies indicate that different Echinacea preparations have dramatically different phytochemical profiles. The available clinical trial data provide no information about the potential role of the different constituents of Echinacea in common cold prevention or treatment. Our hypothesis is that the variation in reported clinical effectiveness may be due to differences in the phytochemical profile of the Echinacea preparations used. This study will address the following specific aims: 1) Evaluate the effectiveness of chemically defined extracts of E. angustifolia root which contain alkamides, echinacoside or polysaccharidelglycoprotein for common cold prevention or treatment; 2) Assess the correlation between specific Echinacea metabolites in serum and nasal secretions and efficacy for prevention and treatment of colds; and 3) Determine the effect of different Echinacea preparations on the host response to rhinovirus infection.
Location Information
Virginia
University of Virginia, Charlottesville, Charlottesville, Virginia, 22904, United States
Ronald B. Turner, MD, Principal Investigator, University of Virginia School of Medicine
J. David Gangemi, PhD, Clemson University
Rudolf Bauer, PhD, Karl-Franzens-Universitaet Graz
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: March 22, 2002
ClinicalTrials.gov Identifier: NCT00032500
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- A Guide for Parents - Questions And Answers: Runny Nose (Division of Bacterial & Mycotic Diseases, NCID, CDC, OPHS, HHS)
- American Academy of Family Physicians

Not Signed In -

